Intelligence / Healthtech & medtech market map / Digital health software and connected health technology / Healthcare analytics, data infrastructure and interoperability / Life sciences and pharma data infrastructure, analytics and clinical decision support
Life sciences and pharma data infrastructure, analytics and clinical decision support
Platforms bought by pharmaceutical and biotechnology companies to integrate clinical trial, real-world evidence and commercial data; run governed data platforms and analytics; and deploy AI-enabled clinical decision support and trial- or protocol-design tooling. Excludes discovery-stage wet-lab informatics and consumer health apps.
- Level
- Niche
- Segmented by
- Customer type
- Buyers
- Pharmaceutical and biotechnology companies (clinical development, medical affairs, RWE and commercial data functions)
- Buying centre
- Head of Clinical Data Sciences / VP Data and Analytics, with IT architecture, Medical Affairs and Regulatory leadership as influencers; centralised procurement with business-unit budget owners
- Launch of a new drug requiring trial and RWE data integration
- Portfolio prioritisation and pipeline review decisions
- Regulatory evidence requirements for label expansion or post-market surveillance
- Enterprise data platform consolidation and cloud migration
- Siloed clinical, trial and commercial data across business units
- Reproducibility and validation burden for regulated analytics
- Tension between speed of AI insight and GxP/validation requirements
- High cost of bespoke data engineering for each programme
How this was sized
Not sized yet
Bottom-up proxy: source [1] gives a 2026 digital health market of USD 98.5bn with software at 62.0% (USD 61.1bn). Applying an assumed 4-7% share of that software pool to life-sciences data infrastructure, analytics and clinical decision support gives roughly USD 2.4-4.3bn (USD 2,400-4,300m); a wider 3-9% band gives USD 1.8-5.5bn. Indicative only, Low confidence: no source sizes this niche, and the source pool is provider-centric, so the share assumption carries wide error.
- Digital Health Market | Global Market Analysis Report - 2035
futuremarketinsights.com · 2026-11-05 - Digital Health Market Size And Share | Industry Report, 2033
grandviewresearch.com · 2026-05-08 - Digital Health Market Size, Share, Growth and Forecast, 2025-2035
credenceresearch.com · 2026-10-16
Alongside it in Healthcare analytics, data infrastructure and interoperability
// Sell into Life sciences and pharma data infrastructure, analytics and clinical decision support